CUE vs SBUX · rev $13.6M vs P/E 76, rev $37.18B
Cue Biopharma (CUE) versus Starbucks Corporation (SBUX) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Starbucks Corporation (SBUX) is a restaurants company listed on NASDAQ. It is led by Brian Niccol.
Latest reported CUE revenue for 2026-06-30 was $13.6M. Net income was -$158.2M. CUE currently screens at market cap $59.5M.
Latest reported SBUX revenue for 2025-09-28 was $37.18B. Net income was $1.86B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
CUE currently screens at market cap $59.5M. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
Not investment advice. Open the CUE and SBUX stock pages for the full models.
Not investment advice.